Largest pharmaceutical companies by total liabilities
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
AbbVie leads the 61 pharmaceutical companies ranked by total liabilities, at DKK 934.8B, ahead of Pfizer (DKK 827.1B) and Johnson & Johnson (DKK 801.7B). Figures as of 18 Nov 2026, 19:01 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- AbbVieDKK 934.8B
- Median
- DKK 14.2B
- Combined market value
- DKK 34.62T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total liabilities ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | DKK 934.8B | DKK 3.46T | DKK 1,955.35 | 2.00% down | 26% up | ||
| 2 | PfizerPFE · Health Care | DKK 827.1B | DKK 1.09T | DKK 191.70 | 1.18% down | 14% up | ||
| 3 | Johnson & JohnsonJNJ · Health Care | DKK 801.7B | DKK 4.51T | DKK 1,871.85 | 1.43% down | 38% up | ||
| 4 | Eli LillyLLY · Health Care | DKK 585.6B | DKK 8.44T | DKK 9,479.25 | 1.72% down | 35% up | ||
| 5 | Merck & CoMRK · Health Care | DKK 573.7B | DKK 2.32T | DKK 941.12 | 3.66% down | 51% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | DKK 487.4B | DKK 836.2B | DKK 409.06 | 2.14% down | 34% up | ||
| 7 | AstraZenecaAZN · Health Care | DKK 445.3B | DKK 1.9T | DKK 1,222.03 | 1.60% down | 2% up | ||
| 8 | NovartisNVS · Health Care | DKK 438.8B | DKK 2T | DKK 1,061.54 | 2.10% down | 25% up | ||
| 9 | SanofiSNY · Health Care | DKK 416.5B | DKK 773.2B | DKK 322.01 | 0.57% down | 4% down | ||
| 10 | GSKGSK · Health Care | DKK 408.5B | DKK 665.6B | DKK 332.06 | 1.03% down | 6% up | ||
| 11 | Novo NordiskNVO · Health Care | DKK 352.7B | DKK 1.19T | DKK 269.14 | 2.95% down | 17% down | ||
| 12 | Takeda PharmaceuticalTAK · Health Care | DKK 344.8B | DKK 465B | DKK 145.54 | 1.29% down | 54% up | ||
| 13 | Abbott LaboratoriesABT · Health Care | DKK 231.3B | DKK 1.23T | DKK 712.03 | 0.20% down | 17% down | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 223.7B | DKK 334.6B | DKK 286.79 | 1.24% down | 74% up | ||
| 15 | ViatrisVTRS · Health Care | DKK 153.2B | DKK 161.8B | DKK 141.17 | 1.32% up | 96% up | ||
| 16 | GrifolsGRFS · Health Care | DKK 91.5B | DKK 39.2B | DKK 57.58 | 2.09% down | 1% up | ||
| 17 | ZoetisZTS · Health Care | DKK 82.7B | DKK 236B | DKK 580.73 | 2.10% up | 29% down | ||
| 18 | Royalty PharmaRPRX · Health Care | DKK 67.5B | DKK 271.9B | DKK 472.94 | 1.06% up | 78% up | ||
| 19 | Regeneron PharmaceuticalsREGN · Health Care | DKK 63.4B | DKK 667.9B | DKK 6,456.77 | 1.06% down | 36% up | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | DKK 50B | DKK 108B | DKK 1,682.47 | 2.58% up | 37% up | ||
| 21 | GenmabGMAB · Health Care | DKK 47.9B | DKK 216.3B | DKK 350.77 | 0.92% down | 70% up | ||
| 22 | Vertex PharmaceuticalsVRTX · Health Care | DKK 47.5B | DKK 930.8B | DKK 3,671.41 | 0.87% up | 27% up | ||
| 23 | Elanco Animal HealthELAN · Health Care | DKK 46.4B | DKK 91.5B | DKK 183.15 | 3.98% up | 20% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | DKK 28.5B | DKK 137.3B | DKK 1,025.01 | 3.88% down | 66% down | ||
| 25 | BeOne MedicinesONC · Health Care | DKK 26.1B | DKK 315.1B | DKK 2,758.58 | 2.03% down | 17% up | ||
| 26 | Amneal PharmaceuticalsAMRX · Health Care | DKK 25B | DKK 52.3B | DKK 150.17 | 4.36% up | 83% up | ||
| 27 | PTC TherapeuticsPTCT · Health Care | DKK 21.2B | DKK 34.3B | DKK 410.88 | 0.10% down | 20% down | ||
| 28 | Ionis PharmaceuticalsIONS · Health Care | DKK 20.7B | DKK 31.7B | DKK 190.51 | 3.71% up | 64% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | DKK 20.5B | DKK 103.6B | DKK 532.01 | 1.67% up | 17% up | ||
| 30 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 14.4B | DKK 85.3B | DKK 102.38 | 1.59% up | 5% up | ||
| 31 | CytokineticsCYTK · Health Care | DKK 14.2B | DKK 48.8B | DKK 350.32 | 0.45% down | 20% down | ||
| 32 | Ascendis PharmaASND · Health Care | DKK 11.1B | DKK 121.1B | DKK 1,845.48 | 0.13% down | 28% up | ||
| 33 | InsmedINSM · Health Care | DKK 10.4B | DKK 180.1B | DKK 820.74 | 1.15% down | 40% down | ||
| 34 | BioMarin PharmaceuticalBMRN · Health Care | DKK 10.3B | DKK 80.1B | DKK 413.52 | 3.73% up | 11% up | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | DKK 6B | DKK 41.8B | DKK 295.54 | 0.90% up | 10% up | ||
| 36 | United TherapeuticsUTHR · Health Care | DKK 5.3B | DKK 168.9B | DKK 3,964.74 | 0.38% down | 23% up | ||
| 37 | Legend BiotechLEGN · Health Care | DKK 5B | DKK 21.4B | DKK 110.52 | 0.68% up | 42% down | ||
| 38 | AlkermesALKS · Health Care | DKK 4.5B | DKK 53.7B | DKK 319.46 | 3.16% up | 58% up | ||
| 39 | Madrigal PharmaceuticalsMDGL · Health Care | DKK 4.5B | DKK 64.2B | DKK 2,764.78 | 3.84% down | 24% down | ||
| 40 | Axsome TherapeuticsAXSM · Health Care | DKK 4.1B | DKK 48.3B | DKK 917.32 | 0.97% down | 7% down | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | DKK 3.7B | DKK 41.1B | DKK 2,057.08 | 2.76% up | 43% up | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | DKK 3.6B | DKK 41B | DKK 627.88 | 0.22% up | 31% up | ||
| 43 | Travere TherapeuticsTVTX · Health Care | DKK 3.3B | DKK 33.4B | DKK 348.11 | 0.02% down | 44% up | ||
| 44 | Roivant SciencesROIV · Health Care | DKK 2.8B | DKK 190.3B | DKK 262.62 | 0.43% down | 90% up | ||
| 45 | TG TherapeuticsTGTX · Health Care | DKK 2.8B | DKK 68.1B | DKK 450.38 | 5.41% up | 107% up | ||
| 46 | Cogent BiosciencesCOGT · Health Care | DKK 2.1B | DKK 33.1B | DKK 190.51 | 0.39% up | 20% down | ||
| 47 | Rhythm PharmaceuticalsRYTM · Health Care | DKK 1.4B | DKK 57.1B | DKK 823.30 | 3.62% up | 13% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 1.3B | DKK 50.9B | DKK 648.32 | 0.04% up | 126% up | ||
| 49 | Corcept TherapeuticsCORT · Health Care | DKK 1.3B | DKK 50.6B | DKK 462.61 | 3.10% down | 8% down | ||
| 50 | ABIVAXABVX · Health Care | DKK 976.2M | DKK 50B | DKK 571.29 | 2.13% up | 27% down | ||
| 51 | Definium TherapeuticsDFTX · Health Care | DKK 734.3M | DKK 26.8B | DKK 196.10 | 2.04% down | 169% up | ||
| 52 | Summit TherapeuticsSMMT · Health Care | DKK 629.1M | DKK 57.4B | DKK 71.78 | 1.27% down | 36% down | ||
| 53 | ErascaERAS · Health Care | DKK 483.7M | DKK 32B | DKK 91.24 | 3.60% down | 403% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | DKK 426.2M | DKK 62.6B | DKK 659.43 | 3.17% up | 286% up | ||
| 55 | Praxis Precision MedicinesPRAX · Health Care | DKK 407.3M | DKK 58.7B | DKK 2,098.61 | 0.96% up | 61% up | ||
| 56 | Protagonist TherapeuticsPTGX · Health Care | DKK 364.4M | DKK 56B | DKK 857.77 | 0.98% up | 46% up | ||
| 57 | Dianthus TherapeuticsDNTH · Health Care | DKK 255.7M | DKK 33.4B | DKK 593.23 | 0.10% up | 113% up | ||
| 58 | Edgewise TherapeuticsEWTX · Health Care | DKK 206.8M | DKK 31.1B | DKK 283.86 | 0.90% down | 88% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | DKK 113.7M | DKK 44.4B | DKK 654.11 | 0.33% down | 241% up | ||
| 60 | Belite BioBLTE · Health Care | DKK 68.6M | DKK 43.6B | DKK 1,074.52 | 0.01% down | 31% up | ||
| 61 | VeradermicsMANE · Health Care | DKK 62.4M | DKK 35.9B | DKK 849.87 | 0.72% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total liabilities is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Where a company reports no total-liabilities line, it is worked out as assets less equity. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8137 DKK).
Questions and answers
Which pharmaceutical companies rank first by total liabilities?
AbbVie (DKK 934.8B), Pfizer (DKK 827.1B) and Johnson & Johnson (DKK 801.7B) are the top three of the 61 pharmaceutical companies ranked by total liabilities as of 18 Nov 2026, 19:01 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by total liabilities.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by total liabilities have a combined market value of DKK 34.62T as of 18 Nov 2026, 19:01 UTC.
What does ranking by total liabilities measure?
Everything the company owes, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by total liabilities”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=total-liabilities
Underlying data: Yahoo Finance; SEC EDGAR.